These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24184827)

  • 1. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.
    Moelans CB; van der Groep P; Hoefnagel LDC; van de Vijver MJ; Wesseling P; Wesseling J; van der Wall E; van Diest PJ
    Cancer Lett; 2014 Mar; 344(1):138-146. PubMed ID: 24184827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.
    Verschuur-Maes AH; Moelans CB; de Bruin PC; van Diest PJ
    Cell Oncol (Dordr); 2014 Apr; 37(2):147-54. PubMed ID: 24692099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.
    Moelans CB; de Weger RA; Monsuur HN; Vijzelaar R; van Diest PJ
    Mod Pathol; 2010 Jul; 23(7):1029-39. PubMed ID: 20473280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Numerical impairments in genes in breast cancer: a multiplex ligation-dependent probe amplification study].
    Matsionis AE; Petrov AV; Gorelik MZ; Zavalishina LE
    Arkh Patol; 2014; 76(4):15-7. PubMed ID: 25306619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer metastasis-associated genes: role in tumour progression to the metastatic state.
    Nicolson GL
    Biochem Soc Symp; 1998; 63():231-43. PubMed ID: 9513727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
    Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 17 copy number changes in male breast cancer.
    Lacle MM; Moelans CB; Kornegoor R; van der Pol C; Witkamp AJ; van der Wall E; Rueschoff J; Buerger H; van Diest PJ
    Cell Oncol (Dordr); 2015 Jun; 38(3):237-45. PubMed ID: 25906114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.
    Wang L; Wang J
    Oncogene; 2012 May; 31(20):2499-511. PubMed ID: 21963843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.
    Norton N; Advani PP; Serie DJ; Geiger XJ; Necela BM; Axenfeld BC; Kachergus JM; Feathers RW; Carr JM; Crook JE; Moreno-Aspitia A; Anastasiadis PZ; Perez EA; Thompson EA
    PLoS One; 2016; 11(4):e0153411. PubMed ID: 27078887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
    Tang MH; Dahlgren M; Brueffer C; Tjitrowirjo T; Winter C; Chen Y; Olsson E; Wang K; Törngren T; Sjöström M; Grabau D; Bendahl PO; Rydén L; Niméus E; Saal LH; Borg Å; Gruvberger-Saal SK
    Oncotarget; 2015 Nov; 6(35):37169-84. PubMed ID: 26439695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
    Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MC; de Bruin PC; Oudejans JJ; Marchionni L; van Diest PJ
    Breast Cancer Res Treat; 2012 Aug; 135(1):49-58. PubMed ID: 22527098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number alterations that predict metastatic capability of human breast cancer.
    Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
    Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 gene status in primary breast cancers and matched distant metastases.
    Tapia C; Savic S; Wagner U; Schönegg R; Novotny H; Grilli B; Herzog M; Barascud AD; Zlobec I; Cathomas G; Terracciano L; Feichter G; Bubendorf L
    Breast Cancer Res; 2007; 9(3):R31. PubMed ID: 17511881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number profiling of oncogenes in ductal carcinoma
    Vermeulen MA; Doebar SC; van Deurzen CHM; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2018 Mar; 25(3):173-184. PubMed ID: 29203614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer.
    Farshid G; Cheetham G; Davies R; Moore S; Rudzki Z
    Diagn Mol Pathol; 2011 Mar; 20(1):11-7. PubMed ID: 21326034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation profiling of distant breast cancer metastases.
    Schrijver WA; Jiwa LS; van Diest PJ; Moelans CB
    Breast Cancer Res Treat; 2015 May; 151(1):41-55. PubMed ID: 25841351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases.
    Kodura MA; Souchelnytskyi S
    Cancer Metastasis Rev; 2015 Dec; 34(4):611-8. PubMed ID: 26328523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
    Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
    Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.